ADRENERGIC-STIMULATION OF PLACENTAL PROGESTERONE PRODUCTION
ADRENERGIC-STIMULATION OF PLACENTAL PROGESTERONE PRODUCTION
复制标题
DOI:
10.1210/jcem-56-5-969
复制
发表时间:
1983-01-01
影响因子:
5.8
通讯作者:
ZELEZNIK, AJ
中科院分区:
文献类型:
--
作者:
CARITIS, SN;HIRSCH, RP;ZELEZNIK, AJ
Cells from term human placentas were maintained in culture, and progesterone production was monitored over 24 h. The .beta.1-adrenergic receptor agonist dobutamine (10-5 M) and the .beta.2-adrenergic receptor agonist terbutaline (10-5 M) increased progesterone production by 36 .+-. 19% and 49 .+-. 8% (.+-. SE), respectively, compared with that in controls (P < 0.001). Propranolol (10-5 M) completely blocked the stimulatory effects of both drugs. The cAMP analog 8-bromo-cAMP (0.5 mM) also significantly altered (increased) progesterone production compared with controls (P < 0.001), but this effect was not blocked to a significant degree by propranolol. The .alpha.-adrenergic receptor agonist methoxamine (10-4-10-6 M) did not significantly alter placental progesterone production compared with controls, and the stimulatory effect of terbutaline on progesterone production was not significantly affected by blockade of the .alpha.-adrenergic receptor with phentolamine. Placental progesterone production can be significantly modulated by stimulation of .beta.-adrenergic, but not by .alpha.-adrenergic, receptors. This response may be mediated by increased intracellular cAMP. These findings may be important in considering other metabolic functions of the placenta and the treatment of preterm labor.